These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10669764)

  • 21. Identification of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma.
    Hundemer M; Schmidt S; Condomines M; Lupu A; Hose D; Moos M; Cremer F; Kleist C; Terness P; Belle S; Ho AD; Goldschmidt H; Klein B; Christensen O
    Exp Hematol; 2006 Apr; 34(4):486-96. PubMed ID: 16569595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.
    Maeurer MJ; Gollin SM; Storkus WJ; Swaney W; Karbach J; Martin D; Castelli C; Salter R; Knuth A; Lotze MT
    Clin Cancer Res; 1996 Apr; 2(4):641-52. PubMed ID: 9816214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid monitoring of immune reconstitution after allogeneic stem cell transplantation--a comparison of different assays for the detection of cytomegalovirus-specific T cells.
    Abu-Khader A; Krause S
    Eur J Haematol; 2013 Dec; 91(6):534-45. PubMed ID: 23952609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunization of patients with melanoma peptide vaccines: immunologic assessment using the ELISPOT assay.
    Pass HA; Schwarz SL; Wunderlich JR; Rosenberg SA
    Cancer J Sci Am; 1998; 4(5):316-23. PubMed ID: 9815296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA class I binding 9mer peptides from influenza A virus induce CD4 T cell responses.
    Wang M; Larsen MV; Nielsen M; Harndahl M; Justesen S; Dziegiel MH; Buus S; Tang ST; Lund O; Claesson MH
    PLoS One; 2010 May; 5(5):e10533. PubMed ID: 20479886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a major histocompatibility complex class I-restricted T-cell epitope in the tumour-associated antigen, 5T4.
    Redchenko I; Harrop R; Ryan MG; Hawkins RE; Carroll MW
    Immunology; 2006 May; 118(1):50-7. PubMed ID: 16630022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel ELISPOT assay to enhance detection of antigen-specific T cells employing antigen-presenting cells expressing vector-driven human B7-1.
    Arlen PM; Gulley JL; Palena C; Marshall J; Schlom J; Tsang KY
    J Immunol Methods; 2003 Aug; 279(1-2):183-92. PubMed ID: 12969559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of antigen presentation on TCR modulation and cytokine release: implications for detection and sorting of antigen-specific CD8+ T cells using HLA-A2 wild-type or HLA-A2 mutant tetrameric complexes.
    Jäger E; Salter R; Castelli C; Höhn H; Freitag K; Karbach J; Neukirch C; Necker A; Knuth A; Maeurer MJ
    J Immunol; 2002 Mar; 168(6):2766-72. PubMed ID: 11884444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flow cytometric determination of intracellular or secreted IFNgamma for the quantification of antigen reactive T cells.
    Asemissen AM; Nagorsen D; Keilholz U; Letsch A; Schmittel A; Thiel E; Scheibenbogen C
    J Immunol Methods; 2001 May; 251(1-2):101-8. PubMed ID: 11292486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro expansion of Ag-specific T cells by HLA-A*0201-transfected K562 cells for immune monitoring.
    Yuan J; Gallardo HF; Rasalan T; Ranganathan R; Wang J; Zhang Y; Panageas K; Stan R; Young JW; Houghton AN; Wolchok JD
    Cytotherapy; 2006; 8(5):498-508. PubMed ID: 17050255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Application of the IFN-gamma ELISPOT assay for monitoring CD8(+) T cell response to specific antigen from hepatocellular carcinoma patients].
    Pang X; Shang X; Lü J
    Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(20):1234-7. PubMed ID: 11825525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a human CD8+ T lymphocyte neo-epitope created by a ras codon 12 mutation which is restricted by the HLA-A2 allele.
    Bergmann-Leitner ES; Kantor JA; Shupert WL; Schlom J; Abrams SI
    Cell Immunol; 1998 Aug; 187(2):103-16. PubMed ID: 9732698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of CD8(+) T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide.
    Lewis JJ; Janetzki S; Schaed S; Panageas KS; Wang S; Williams L; Meyers M; Butterworth L; Livingston PO; Chapman PB; Houghton AN
    Int J Cancer; 2000 Aug; 87(3):391-8. PubMed ID: 10897045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the interferon-gamma ELISPOT-assay for quantification of peptide specific T lymphocytes from peripheral blood.
    Schmittel A; Keilholz U; Scheibenbogen C
    J Immunol Methods; 1997 Dec; 210(2):167-74. PubMed ID: 9520299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melanoma-reactive class I-restricted cytotoxic T cell clones are stimulated by dendritic cells loaded with synthetic peptides, but fail to respond to dendritic cells pulsed with melanoma-derived heat shock proteins in vitro.
    Fleischer K; Schmidt B; Kastenmüller W; Busch DH; Drexler I; Sutter G; Heike M; Peschel C; Bernhard H
    J Immunol; 2004 Jan; 172(1):162-9. PubMed ID: 14688322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes.
    Maeurer MJ; Chan HW; Karbach J; Salter RD; Knuth A; Lotze MT; Storkus WJ
    Eur J Immunol; 1996 Nov; 26(11):2613-23. PubMed ID: 8921947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
    Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
    Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Detection of antigen-epitope-specific cytotoxic T lymphocytes in patients with hepatitis B virus infection by enzyme linked immunospot assay].
    Zhang HP; Yan HP; Zhang YH; Feng X; Zhao Y; Liao HY; Liu YM; Chen Y; Tan YF; Liu Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Aug; 43(8):690-4. PubMed ID: 20021848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
    Fenton RG; Turcovski-Corrales SM; Taub DD
    J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitation of antigen-reactive T cells in peripheral blood by IFNgamma-ELISPOT assay and chromium-release assay: a four-centre comparative trial.
    Scheibenbogen C; Romero P; Rivoltini L; Herr W; Schmittel A; Cerottini JC; Woelfel T; Eggermont AM; Keilholz U
    J Immunol Methods; 2000 Oct; 244(1-2):81-9. PubMed ID: 11033021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.